265 related articles for article (PubMed ID: 34475389)
1. Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer.
Schachter NF; Adams JR; Skowron P; Kozma KJ; Lee CA; Raghuram N; Yang J; Loch AJ; Wang W; Kucharczuk A; Wright KL; Quintana RM; An Y; Dotzko D; Gorman JL; Wojtal D; Shah JS; Leon-Gomez P; Pellecchia G; Dupuy AJ; Perou CM; Ben-Porath I; Karni R; Zacksenhaus E; Woodgett JR; Done SJ; Garzia L; Sorana Morrissy A; Reimand J; Taylor MD; Egan SE
Nat Commun; 2021 Sep; 12(1):5238. PubMed ID: 34475389
[TBL] [Abstract][Full Text] [Related]
2. Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.
Chen L; Jenjaroenpun P; Pillai AM; Ivshina AV; Ow GS; Efthimios M; Zhiqun T; Tan TZ; Lee SC; Rogers K; Ward JM; Mori S; Adams DJ; Jenkins NA; Copeland NG; Ban KH; Kuznetsov VA; Thiery JP
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2215-E2224. PubMed ID: 28251929
[TBL] [Abstract][Full Text] [Related]
3. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
[TBL] [Abstract][Full Text] [Related]
4. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
6. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
[TBL] [Abstract][Full Text] [Related]
7. Identification of Sleeping Beauty transposon insertions in solid tumors using linker-mediated PCR.
Janik CL; Starr TK
J Vis Exp; 2013 Feb; (72):e50156. PubMed ID: 23407503
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity associated with uniparental disomy in breast carcinoma.
Murthy SK; DiFrancesco LM; Ogilvie RT; Demetrick DJ
Mod Pathol; 2002 Dec; 15(12):1241-50. PubMed ID: 12481003
[TBL] [Abstract][Full Text] [Related]
9. Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer.
Jiang Z; Ju Y; Ali A; Chung PED; Skowron P; Wang DY; Shrestha M; Li H; Liu JC; Vorobieva I; Ghanbari-Azarnier R; Mwewa E; Koritzinsky M; Ben-David Y; Woodgett JR; Perou CM; Dupuy A; Bader GD; Egan SE; Taylor MD; Zacksenhaus E
Nat Commun; 2023 Jul; 14(1):4313. PubMed ID: 37463901
[TBL] [Abstract][Full Text] [Related]
10. Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis.
Zhong R; Bao R; Faber PW; Bindokas VP; Bechill J; Lingen MW; Spiotto MT
Cancer Res; 2015 Sep; 75(18):3958-3969. PubMed ID: 26294213
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.
Ahomadegbe JC; Tourpin S; Kaghad M; Zelek L; Vayssade M; Mathieu MC; Rochard F; Spielmann M; Tursz T; Caput D; Riou G; Bénard J
Oncogene; 2000 Nov; 19(47):5413-8. PubMed ID: 11103943
[TBL] [Abstract][Full Text] [Related]
12. Mobile element insertions and associated structural variants in longitudinal breast cancer samples.
Steely CJ; Russell KL; Feusier JE; Qiao Y; Tavtigian SV; Marth G; Jorde LB
Sci Rep; 2021 Jun; 11(1):13020. PubMed ID: 34158539
[TBL] [Abstract][Full Text] [Related]
13. Transposon-mediated mutagenesis in somatic cells: identification of transposon-genomic DNA junctions.
Largaespada DA; Collier LS
Methods Mol Biol; 2008; 435():95-108. PubMed ID: 18370070
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Insertional Mutagenesis Screen Identifies Novel Genes Driving Breast Cancer Metastasis.
Miskey C; Botezatu L; Temiz NA; Gogol-Döring A; Bartha Á; Győrffy B; Largaespada DA; Ivics Z; Sebe A
Mol Cancer Res; 2022 Oct; 20(10):1502-1515. PubMed ID: 35687718
[TBL] [Abstract][Full Text] [Related]
15. A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
de la Rosa J; Weber J; Friedrich MJ; Li Y; Rad L; Ponstingl H; Liang Q; de Quirós SB; Noorani I; Metzakopian E; Strong A; Li MA; Astudillo A; Fernández-García MT; Fernández-García MS; Hoffman GJ; Fuente R; Vassiliou GS; Rad R; López-Otín C; Bradley A; Cadiñanos J
Nat Genet; 2017 May; 49(5):730-741. PubMed ID: 28319090
[TBL] [Abstract][Full Text] [Related]
16. Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.
Ikink GJ; Boer M; Bakker ERM; Vendel-Zwaagstra A; Klijn C; Ten Hoeve J; Jonkers J; Wessels LF; Hilkens J
Oncogene; 2018 Mar; 37(12):1594-1609. PubMed ID: 29326437
[TBL] [Abstract][Full Text] [Related]
17. SB Driver Analysis: a Sleeping Beauty cancer driver analysis framework for identifying and prioritizing experimentally actionable oncogenes and tumor suppressors.
Newberg JY; Black MA; Jenkins NA; Copeland NG; Mann KM; Mann MB
Nucleic Acids Res; 2018 Sep; 46(16):e94. PubMed ID: 29846651
[TBL] [Abstract][Full Text] [Related]
18. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
Hawthorn L; Luce J; Stein L; Rothschild J
BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
[TBL] [Abstract][Full Text] [Related]
19. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
[TBL] [Abstract][Full Text] [Related]
20. The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer.
Crawford J; Ianzano L; Savino M; Whitmore S; Cleton-Jansen AM; Settasatian C; d'apolito M; Seshadri R; Pronk JC; Auerbach AD; Verlander PC; Mathew CG; Tipping AJ; Doggett NA; Zelante L; Callen DF; Savoia A
Genomics; 1999 Feb; 56(1):90-7. PubMed ID: 10036189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
